Covered recipient · General Payments record
AKASH MUKESH SHAH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$1,417.31
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $414.07 | 26 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $147.87 | 13 |
| Lilly USA, LLC | $79.08 | 5 |
| Acerta Pharma LLC | $73.60 | 1 |
| ABBVIE INC. | $51.67 | 3 |
| GlaxoSmithKline, LLC. | $28.76 | 2 |
| Amgen Inc. | $18.52 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $13.35 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998925079 | CMS |
| AbbVie Inc. | $22.68 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998925083 | CMS |
| AbbVie Inc. | $15.64 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998925087 | CMS |
| Amgen Inc. | $18.52 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019779691 | CMS |
| AstraZeneca Pharmaceuticals LP | $73.60 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015750043 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.57 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997050357 | CMS |
| GlaxoSmithKline, LLC. | $15.82 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003490019 | CMS |
| GlaxoSmithKline, LLC. | $12.94 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003490015 | CMS |
| Lilly USA, LLC | $14.93 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031224829 | CMS |
| Lilly USA, LLC | $20.98 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031221977 | CMS |
| Lilly USA, LLC | $16.58 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031224831 | CMS |
| Lilly USA, LLC | $13.84 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031232861 | CMS |
| Lilly USA, LLC | $12.75 | 06/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031232711 | CMS |
| Novo Nordisk Inc | $15.06 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724113 | CMS |
| Novo Nordisk Inc | $13.51 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724089 | CMS |
| Novo Nordisk Inc | $12.08 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724063 | CMS |
| Novo Nordisk Inc | $10.59 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724035 | CMS |
| Novo Nordisk Inc | $20.94 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724137 | CMS |
| Novo Nordisk Inc | $12.11 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724075 | CMS |
| Novo Nordisk Inc | $13.70 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724103 | CMS |
| Novo Nordisk Inc | $8.40 | 06/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724013 | CMS |
| Novo Nordisk Inc | $10.12 | 07/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724023 | CMS |
| Novo Nordisk Inc | $0.20 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002723989 | CMS |
| Novo Nordisk Inc | $12.01 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724051 | CMS |
| Novo Nordisk Inc | $17.62 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724123 | CMS |
| Novo Nordisk Inc | $1.53 | 11/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002724001 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.